Christopher J. Reading
Net Worth

Last updated:

What is Christopher J. Reading net worth?

The estimated net worth of Mr. Christopher J. Reading is at least $41,162,075 as of 30 May 2024. He owns shares worth $7,055,594 as insider, has earned $6,936,481 from insider trading and has received compensation worth at least $27,170,000 in U.S. Physical Therapy, Inc..

What is the salary of Christopher J. Reading?

Mr. Christopher J. Reading salary is $1,430,000 per year as Pres, Chief Executive Officer & Director in U.S. Physical Therapy, Inc..

How old is Christopher J. Reading?

Mr. Christopher J. Reading is 61 years old, born in 1964.

What stocks does Christopher J. Reading currently own?

As insider, Mr. Christopher J. Reading owns shares in one company:

Company Title Shares Price per share Total value
U.S. Physical Therapy, Inc. (USPH) Pres, Chief Executive Officer & Director 95,838 $73.62 $7,055,594

What does U.S. Physical Therapy, Inc. do?

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

Christopher J. Reading insider trading

U.S. Physical Therapy, Inc.

Mr. Christopher J. Reading has made 36 insider trades between 2006-2024, according to the Form 4 filled with the SEC. Most recently he sold 2,900 units of USPH stock worth $290,754 on 30 May 2024.

The largest trade he's ever made was exercising 100,000 units of USPH stock on 15 Jun 2011. As of 30 May 2024 he still owns at least 95,838 units of USPH stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 2,900 $100.26 $290,754
Sale
Common Stock 1,000 $100.13 $100,130
Sale
Common Stock 1,100 $102.13 $112,343
Sale
Common Stock 5,000 $90 $450,000
Sale
Common stock 10,000 $90.01 $900,100
Sale
Common Stock 12,000 $93.89 $1,126,680
Sale
Common Stock 6,000 $106.67 $640,020
Sale
Common Stock 4,899 $135.12 $661,953
Sale
Common Stock 1,500 $135.07 $202,605
Sale
Common Stock 601 $135.39 $81,369
Sale
Common Stock 9,860 $120.52 $1,188,327
Sale
Common Stock 10,000 $118.22 $1,182,200
Sale
Common Stock 8,768 N/A N/A
Sale
Common Stock 451 N/A N/A
Sale
Common Stock 781 N/A N/A
Sale
Common Stock 2,672 N/A N/A
Sale
Common Stock 8,689 N/A N/A
Sale
Common Stock 13,639 N/A N/A
Sale
Common Stock 12,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 8,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 3,152 N/A N/A
Sale
common stock 21,848 N/A N/A
Sale
Common Stock 22,600 N/A N/A
Sale
Common Stock 2,400 N/A N/A
Sale
Common Stock 9,159 N/A N/A
Sale
Common Stock 600 N/A N/A
Sale
Common Stock 10,241 N/A N/A
Sale
Common Stock 18,271 N/A N/A
Sale
Common Stock 1,729 N/A N/A
Option
Director's Right to Buy 50,000 N/A N/A
Option
Common Stock 50,000 N/A N/A
Sale
Common Stock 28,537 N/A N/A
Sale
Common Stock 21,556 N/A N/A
Option
Director's Stock Option Right to Buy 100,000 N/A N/A
Option
Common Stock 100,000 N/A N/A
Sale
Common Stock 39,500 N/A N/A
Sale
Common Stock 6,500 N/A N/A
Option
Common Stock 100,000 N/A N/A
Option
Director's Stock Option Right to Buy 100,000 N/A N/A
Sale
Common Stock 25,000 N/A N/A
Purchase
Common Stock 4,000 N/A N/A
Purchase
Common Stock 1,000 N/A N/A

U.S. Physical Therapy key executives

U.S. Physical Therapy, Inc. executives and other stock owners filed with the SEC: